期刊文献+

^(18)F-FDG PET/CT对肝内胆管癌的诊断价值研究 被引量:9

Evaluation of the role of ^(18)F-FDG PET/CT in the diagnosis of intrahepatic cholangiocarcinoma
暂未订购
导出
摘要 目的探讨^(18)F-FDG PET/CT对肝内胆管癌的临床诊断价值,探寻鉴别肝内胆管癌与良性病灶的最佳放射摄取半定量诊断界值。方法收集2010年8月~2012年12月因常规影像学怀疑肝内胆管癌并行PET/CT检查患者的资料。分别使用视觉分析法、SUV_(max)法、T/N比法及综合分析法进行诊断,以手术病理结果为金标准,计算并比较各种方法诊断肝内胆管癌的效能。结果共入组51例患者,2例为肝细胞癌,39例肝内胆管癌及10例良性病灶;PET/CT诊断肝内胆管癌的敏感度92.3%;特异度75.0%;准确度88.2%;阳性预测值92.3%;阴性预测值75.0%。39例肝内胆管癌的SUV_(max)均值是9.65±4.44,10例良性病灶的SUV_(max)为5.17±2.30,差异有显著统计学意义(P<0.05);39例肝内胆管癌的T/N均值是4.29±2.16,10例良性病灶是2.03±0.74,差异有显著统计学意义(P<0.05)。绘制诊断胆管癌的SUV_(max)、T/N的ROC曲线。当SUV_(max)最佳诊断界值是4.05时,诊断肝内胆管癌的敏感度和特异度分别为94.9%、50.0%。当T/N最佳诊断界值是2.85时,诊断肝内胆管癌的敏感度和特异度分别为76.9%、90.0%。视觉分析法较T/N法有较高的敏感度(P<0.05),T/N法较视觉分析法有较高的特异度(P<0.05);SUV_(max)法较T/N法有较高的敏感度(P<0.05)。结论PET/CT诊断肝内胆管癌有较高诊断效能,但仍存在部分假阳性和假阴性,合理应用各项代谢参数并结合同层CT及临床资料有助于进一步提高诊断效能。 Objective To assess the value of -(18)F-FDG PET / CT in patients with intrahepatic cholangiocarcinoma and the efficacy of SUV_(max) and T / N ratio for differentiating malignant from benign hepatic lesions..Methods 51 patients with suspected intrahepatic cholangiocarcinomas who underwent -(18)F-FDG PET / CT scan between August 2010 and December 2012 were included in the analysis using visual assessment, SUV_(max), T / N ratio, and receiver operating characteristic(ROC) curves. Using SUV_(max)cutoff values of 4.05,.the sensitivity and specificity for diagnosing intrahepatic cholangiocarcinoma were 94.9% and 50.0%, respectively.With T / N cutoff value of 2.85, the sensitivity and specificity were 76.9% and 90.0%, respectively. Visual analysis had significantly higher sensitivity and lower specificity than T / N(P〈0.05)..SUV_(max) also had significantly higher sensitivity than T / N(P〈0.05).Results Of 51 patients, the final histological diagnosis was hepatocellular carcinoma(2), cholangiocarcinoma(39) and benign disease(10). The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of -(18)F-FDG PET / CT in primary tumor detection were 92.3%, 75.0%, 88.2%, 92.3%, and 75.0%, respectively. The SUV_(max) of intrahepatic cholangiocarcinoma( 9. 65 ± 4. 44) was significantly( P〈0. 05) higher than that of benign lesions( 5. 17 ± 2. 30). The T / N of malignancy(4.29 ±2.16) was also significantly(P〈0.05) higher than that of benign lesions(2.03 ±0.74). Conclusion -(18)F-FDG PET / CT has high sensitivity and positive predictive value for differentiating intrahepatic cholangiocarcinoma and benign lesions.
出处 《影像诊断与介入放射学》 2016年第2期161-166,共6页 Diagnostic Imaging & Interventional Radiology
基金 国家自然科学基金(81170435 81471714) 上海市卫生局项目(XBR2011040)
关键词 肝内胆管癌 正电子发射体层摄影术 体层摄影术 X线计算机 氟脱氧葡萄糖 Intrahepatic cholangiocarcinoma Positron-emission tomography Tomography X-ray computed Fluorode oxyglucose
  • 相关文献

参考文献29

  • 1Simo KA,Halpin LE,Mc Brier NM,et al.Multimodality treatment of intrahepatic cholangiocarcinoma:.a review..J Surg Oncol,2016,113:62-83.
  • 2Brandi G,Venturi M,Pantaleo MA,et al.Cholangiocarcinoma:current opinion on clinical practice diagnostic and therapeutic algorithms:.a review of the literature and a long-standing experience of a referral center.Dig Liver Dis,2016,48:231-241.
  • 3张建,贾宁阳,余仲飞,杨剑,刘晓东,胡胜平,冯菲,孙高峰,程超,王书中,左长京.FDG PET与增强CT异机融合图像在胰腺病变良恶性鉴别诊断及胰腺癌分期中的价值[J].中华胰腺病杂志,2014,14(6):374-379. 被引量:11
  • 4王少雁,张建,孙高峰,程超,刘庆华,彭婕,韩一平,郑建明,孔令山,左长京.^18F-FDG PET/CT最大标准摄取值联合HRCT在肺癌诊断中的价值和影响因素分析[J].中华核医学与分子影像杂志,2013,33(1):29-33. 被引量:37
  • 5王玉涛,汪建华,张建,孙高峰,程超,王涛,杨剑,潘桂霞,邓生德,左长京.食管癌^18氟-氟代脱氧葡萄糖PET/CT检查特征[J].中华消化外科杂志,2015,14(12):1047-1052. 被引量:10
  • 6Takekuma M,Maeda M,Ozawa T,et al.Positron emission tomography with18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer.Int J Clin Oncol,2005,10:177-181.
  • 7Wu Y,Li P,Zhang H,et al.Diagnostic value of fluorine 18fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.Int J Cancer,2013,132:E37-E47.
  • 8Maffione AM,Galeotti F,Capirci C,et al.When and why to use FDG PET/CT in locally advanced rectal cancer:non-small-cell two scenarios.Clin Nucl Med,2014,39:528-530.
  • 9Jiang L,Tan H,Panje CM,et al.Role of18F-FDG PET/CTimaging in intrahepatic cholangiocarcinoma..Clin Nucl Med,2016,41:1-7.
  • 10Weber SM,Ribero D,O'Reilly EM,et al.Intrahepatic cholangiocarcinoma:expert consensus statement.HPB,2015,17:669-680.

二级参考文献55

共引文献195

同被引文献81

引证文献9

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部